- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Privia Health Group Beats Q4 Earnings Expectations
The healthcare technology company reported $0.25 EPS, exceeding analyst estimates by $0.21.
Mar. 3, 2026 at 6:47am
Got story updates? Submit your updates here. ›
Privia Health Group (NASDAQ:PRVA) released its Q4 2025 earnings results on Thursday, reporting $0.25 earnings per share, topping analysts' consensus estimates of $0.04 by $0.21. The company's revenue also grew 17.4% year-over-year to $541.17 million, exceeding the $516.61 million expected by analysts.
Why it matters
Privia Health Group's strong financial performance demonstrates the company's ability to drive growth and profitability as it continues to partner with independent physicians, medical groups, and health systems to transform patient care delivery through its technology platform and clinically integrated network.
The details
Privia Health Group reported a return on equity of 3.12% and a net margin of 1.08% for the quarter. The company's stock price fell $1.16 on Friday to close at $23.75 per share, with trading volume of 1.8 million shares.
- Privia Health Group released its Q4 2025 earnings results on Thursday, February 28, 2026.
- In the same quarter a year earlier, the company posted $0.21 EPS.
The players
Privia Health Group
A physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care.
David Mountcastle
The Chief Financial Officer of Privia Health Group.
Matthew Shawn Morris
A Director at Privia Health Group.
What’s next
Privia Health Group's stock price and trading volume will continue to be monitored by investors and analysts as the company executes on its growth strategy.
The takeaway
Privia Health Group's Q4 2025 earnings beat highlights the company's ability to drive revenue growth and profitability through its innovative physician enablement platform, positioning it well to capitalize on the ongoing shift towards value-based care models in the healthcare industry.
